Table 1.
Patient characteristics and the SLC25A43 expression in the HER2-positive breast cancer cohort
|
Parameters |
No. of cases total in the cohort (%) |
Mean values of total cases in the cohort |
SLC25A43 expression |
P-value |
|
|---|---|---|---|---|---|
| Negative/Low | Medium/High | ||||
| All |
85 |
|
26 |
45 |
|
| Patient's age |
|
|
|
|
|
| ≤50 years |
22 (26) |
|
|
|
|
| >50 years |
62 (73) |
|
|
|
|
| Mean age (years) |
|
58.5 |
62 |
58 |
0.269 |
| ND |
1 (1) |
|
|
|
|
| Tumour size |
|
|
|
|
|
| ≤2 cm |
33 (39) |
|
|
|
|
| >2 cm |
50 (59) |
|
|
|
|
| Mean size (mm) |
|
28 |
25 |
30 |
0.13 |
| ND |
2 (2) |
|
|
|
|
| S-phase |
|
|
|
|
|
| Include cases |
70 (82) |
|
|
|
|
| Mean S-phase (%) |
|
10.7 |
9.4 |
12.6 |
0.024 |
| ND |
15 (18) |
|
|
|
|
| LN metastasis |
|
|
|
|
|
| Negative |
27 (32) |
|
8 |
15 |
0.859 |
| Positive |
55 (65) |
|
17 |
29 |
|
| ND |
3 (4) |
|
|
|
|
| ER status |
|
|
|
|
|
| Negative |
38 (45) |
|
12 |
20 |
0.951 |
| Positive |
41 (48) |
|
13 |
21 |
|
| ND |
6 (7) |
|
|
|
|
| PgR status |
|
|
|
|
|
| Negative |
45 (53) |
|
16 |
24 |
0.659 |
| Positive |
33 (39) |
|
9 |
17 |
|
| ND | 7 (8) | ||||
LN, lymph node; ER, oestrogen receptor; PgR, progesterone receptor; ND, not determined.